193 related articles for article (PubMed ID: 5583441)
21. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
Heller B
Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
[No Abstract] [Full Text] [Related]
22. Determination of bufotenin in the urine of schizophrenics.
Fischer E; Spatz H
Int J Neuropsychiatry; 1967 Jun; 3(3):226-8. PubMed ID: 6034731
[No Abstract] [Full Text] [Related]
23. [Therapeutic effect of triperidol].
Cwynar S; Pionkowski J; Tomczak W; Tyszka E
Psychiatr Pol; 1968; 2(6):627-32. PubMed ID: 5730286
[No Abstract] [Full Text] [Related]
24. Electroencephalographic effects of trifluperidol.
Itil T; Fink M
Dis Nerv Syst; 1969 Aug; 30(8):524-30. PubMed ID: 5809787
[No Abstract] [Full Text] [Related]
25. Influence of triperidol on the urinary elimination of bufotenin in schizophrenia.
Acebal EM
Behav Neuropsychiatry; 1969 Aug; 1(5):31. PubMed ID: 5398117
[No Abstract] [Full Text] [Related]
26. [Central and peripheral secondary effects of some butyrophenones].
Salvini L; Frosali L; Gigli M
Minerva Anestesiol; 1969 Apr; 35(4):334-44. PubMed ID: 5789993
[No Abstract] [Full Text] [Related]
27. Newer treatment for schizophrenia.
Tourney G
J Iowa Med Soc; 1972 Sep; 62(9):491-2. PubMed ID: 5051851
[No Abstract] [Full Text] [Related]
28. Studies on the elimination of bufotenin in urine.
Sireix DW; Marini FA
Behav Neuropsychiatry; 1969 Aug; 1(5):29-31. PubMed ID: 5398115
[No Abstract] [Full Text] [Related]
29. [Palatoschisis induced by trifluperidol in mice].
Vichi F; Pierleoni P; Orlando S; Tollaro I
Sperimentale; 1968; 118(4):245-51. PubMed ID: 5740872
[No Abstract] [Full Text] [Related]
30. Combined treatment with ECT and antipsychotic drugs in schizophrenia.
Weinstein MR; Fischer A
Dis Nerv Syst; 1971 Dec; 32(12):801-8. PubMed ID: 5139202
[No Abstract] [Full Text] [Related]
31. [Therapeutic results obtained with triperidol in a group of chronic schizophrenics].
Motta E; Spadaro P
Riv Sper Freniatr Med Leg Alien Ment; 1967 Jun; 91(3):802-17. PubMed ID: 5614833
[No Abstract] [Full Text] [Related]
32. On the distribution and metabolism of neuroleptic drugs. 3. Pharmacokinetics of trifluperidol.
Lewi PJ; Heykants JJ; Janssen PA
Arzneimittelforschung; 1970 Nov; 20(11):1701-5. PubMed ID: 5536974
[No Abstract] [Full Text] [Related]
33. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
Nurowska K; Welbel L
Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
[No Abstract] [Full Text] [Related]
34. A comparison of two butyrophenones with trifluoperazine.
Marjerrison G; Hrychuk W; Varsanyi EI
Can Psychiatr Assoc J; 1966 Feb; 11(1):26-30. PubMed ID: 5322990
[No Abstract] [Full Text] [Related]
35. [A year's use of R2498 with chronic ambulatory schizophrenic patients].
Madalena JC
Hospital (Rio J); 1965 Aug; 68(2):279-84. PubMed ID: 5295121
[No Abstract] [Full Text] [Related]
36. [Therapeutic evaluation of R2498 (triperidol) in hospitalized schizophrenic patients].
Bueno JR
J Bras Psiquiatr; 1965; 14(1):81-91. PubMed ID: 5888213
[No Abstract] [Full Text] [Related]
37. [Complementary neurolepsy].
Petrilowitsch N; Herzog R
Psychiatr Neurol (Basel); 1966; 151(4):195-207. PubMed ID: 5925592
[No Abstract] [Full Text] [Related]
38. [Effect of triperidol on glucose and pyruvic acid metabolism in rat cerebral cortex slices].
Gatti G; Michalek H; Pocchiari F
Ann Ist Super Sanita; 1966; 2(2):277-86. PubMed ID: 6005037
[No Abstract] [Full Text] [Related]
39. Comprehensive therapy of the schizophrenic syndrome.
Cancro R
Curr Psychiatr Ther; 1976; 16():91-100. PubMed ID: 991653
[No Abstract] [Full Text] [Related]
40. [Study on the presence of bufotenin in the urine of schizophrenic patients].
Sireix DW; Marini FA
Rev Sanid Milit Argent; 1967; 66(1):14-21. PubMed ID: 5629061
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
